MAP1B Protein

Migration, Crosslink

📖

MAP1B Protein

active

wiki page Created: 2026-04-02T07:19:11 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-map1b-protein

📖 Wiki Page

protein1628 wordssynced 2026-04-02

MAP1B Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MAP1B Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Amino Acid Position</td>
</tr>
<tr>
<td class="label">N-terminal projection domain</td>
<td>1-1800</td>
</tr>
<tr>
<td class="label">Microtubule-binding domain</td>
<td>1800-2200</td>
</tr>
<tr>
<td class="label">C-terminal domain</td>
<td>2200-2700</td>
</tr>
<tr>
<td class="label">Phosphorylation sites</td>
<td>Multiple</td>
</tr>
<tr>
<td class="label">Kinase</td>
<td>Regulation</td>
</tr>
<tr>
<td class="label">GSK3β</td>
<td>Major phosphorylating kinase</td>
</tr>
<tr>
<td class="label">CDK5</td>
<td>Activity-dependent</td>
</tr>
<tr>
<td class="label">MAPK/ERK</td>
<td>Growth factor signaling</td>
</tr>
<tr>
<td class="label">PKA</td>
<td>cAMP-dependent</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">29 edges</a></td>
</tr>
</table>

...

MAP1B Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MAP1B Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Amino Acid Position</td>
</tr>
<tr>
<td class="label">N-terminal projection domain</td>
<td>1-1800</td>
</tr>
<tr>
<td class="label">Microtubule-binding domain</td>
<td>1800-2200</td>
</tr>
<tr>
<td class="label">C-terminal domain</td>
<td>2200-2700</td>
</tr>
<tr>
<td class="label">Phosphorylation sites</td>
<td>Multiple</td>
</tr>
<tr>
<td class="label">Kinase</td>
<td>Regulation</td>
</tr>
<tr>
<td class="label">GSK3β</td>
<td>Major phosphorylating kinase</td>
</tr>
<tr>
<td class="label">CDK5</td>
<td>Activity-dependent</td>
</tr>
<tr>
<td class="label">MAPK/ERK</td>
<td>Growth factor signaling</td>
</tr>
<tr>
<td class="label">PKA</td>
<td>cAMP-dependent</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">29 edges</a></td>
</tr>
</table>

MAP1B (Microtubule-Associated Protein 1B) is one of the earliest and most abundant microtubule-associated proteins expressed in developing neurons. Originally identified as a key regulator of axonal growth and guidance during neurodevelopment[@gonzalez2019], MAP1B has emerged as a critical player in neurodegenerative disease pathogenesis. The protein is essential for establishing neuronal polarity, maintaining axonal integrity, and coordinating intracellular transport. In Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative disorders, MAP1B dysfunction contributes to cytoskeletal disruption, impaired axonal transport, and synaptic failure. This page provides a comprehensive overview of MAP1B structure, function, and its role in neurodegeneration.

Overview

MAP1B is a large, multifunctional protein that plays dual roles in both developing and mature neurons. During embryonic development, MAP1B is expressed at high levels and is essential for axonal elongation, pathfinding, and the establishment of neuronal polarity. In the adult brain, MAP1B continues to be expressed at lower levels, where it maintains cytoskeletal stability and regulates synaptic function. The protein has been implicated in multiple neurodegenerative diseases, including AD, PD, Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS), where its dysregulation contributes to the characteristic pathological features of each disorder[@takei2020][@badhwar2018].

The MAP1B gene is located on chromosome 5q33.2 and encodes a protein of approximately 2700 amino acids with a molecular weight of ~300 kDa for the heavy chain. The protein exists as a complex of one heavy chain (MAP1B-HC) and multiple light chains (MAP1B-LC1, LC2, LC3) that are generated through alternative splicing and post-translational processing[@takahashi2020]. Each subunit has distinct functions: the heavy chain provides the structural scaffold, while the light chains mediate microtubule binding and protein-protein interactions.

Protein Structure and Domains

Domain Organization

MAP1B possesses a distinctive domain architecture optimized for its role in microtubule organization:

Light Chain Subunits

The MAP1B light chains are crucial for its functional diversity:

MAP1B-LC1: Primary microtubule-binding light chain, essential for axonal elongation
MAP1B-LC2: Mediates interactions with actin cytoskeleton and signaling proteins
MAP1B-LC3: Involved in autophagy and lysosomal function, contains the LC3-homology region

Post-Translational Modifications

MAP1B function is tightly regulated by post-translational modifications:

Phosphorylation: Multiple serine/threonine phosphorylation sites are regulated by GSK3β, CDK5, PKA, and MAPK/ERK pathways[@wang2021][@liu2022]

Acetylation: Microtubule acetylation affects MAP1B binding and stability

Ubiquitination: Regulates MAP1B turnover and degradation

Sumoylation: Modulates subcellular localization and interactions

Molecular Functions

Axon Growth and Guidance

During neuronal development, MAP1B is essential for proper axon formation and guidance:

Axonal Elongation: MAP1B promotes microtubule assembly in growing axons through direct binding along the microtubule lattice. The protein stabilizes microtubules against depolymerization and facilitates the addition of new tubulin subunits at the growth cone[@gonzalez2019].

Growth Cone Dynamics: MAP1B localizes to growth cones where it regulates actin-microtubule coupling and controls steering decisions. The protein responds to guidance cues by modulating microtubule polymerization rates.

Neuronal Polarity: Establishment of axon-dendrite polarity requires asymmetric distribution of MAP1B. The protein accumulates preferentially in the future axon, where it drives axonal specification and maintains polarity.

Fasciculation and Tract Formation: MAP1B-mediated axonal bundling contributes to the formation of major fiber tracts in the developing brain.

Microtubule Organization

In mature neurons, MAP1B continues to play critical roles in cytoskeletal organization:

Microtubule Stabilization: MAP1B binding protects microtubules from depolymerization under cellular stress
Motor Protein Coordination: MAP1B facilitates transport by both kinesin and dynein motors through its interactions with motor protein adaptors
Microtubule Lattice Organization: MAP1B binding modifies microtubule properties, affecting tubulin post-translational modifications

Synaptic Function

At synapses, MAP1B contributes to both presynaptic and postsynaptic functions:

Presynaptic Terminals: MAP1B regulates synaptic vesicle pools and modulates neurotransmitter release
Postsynaptic Sites: The protein associates with dendritic spines and postsynaptic densities, where it influences spine morphology and plasticity
Activity-Dependent Plasticity: MAPK/ERK-mediated phosphorylation of MAP1B regulates activity-dependent structural changes at synapses

Expression Pattern

Developmental Regulation

MAP1B expression follows a precise temporal pattern:

Embryonic Development: Highest expression during embryogenesis (E10-P21 in mice)
Postnatal Period: Gradual decline but maintained expression in specific brain regions
Adult Brain: Lower levels in cortex, hippocampus, and specific subpopulations of neurons

Brain Regional Distribution

MAP1B is widely expressed throughout the central and peripheral nervous systems:

Enriched Regions: Forebrain, hippocampus, cortex, cerebellum
Cell Type Specificity: Primarily neuronal expression; some glial expression under pathological conditions
Subcellular Localization: Axons, growth cones, synaptic terminals, dendritic compartments

Role in Alzheimer's Disease

Pathological Changes

In Alzheimer's disease, MAP1B undergoes several alterations that contribute to neurodegeneration:

Altered Expression: MAP1B expression and phosphorylation are significantly altered in AD brain[@takei2020]

Hyperphosphorylation: Enhanced phosphorylation at specific sites affects microtubule binding

Interaction with Tau: MAP1B and tau share overlapping binding sites on microtubules and may influence each other's pathology[@meyer2021][@jacobson2021]

Cytoskeletal Disruption: Loss of MAP1B function contributes to microtubule instability and neuronal dysfunction

Amyloid-Beta Effects

Aβ oligomers directly affect MAP1B function:

Aβ exposure reduces MAP1B-microtubule binding
Oxidative stress induced by Aβ impairs MAP1B phosphorylation regulation
Synaptic dysfunction correlates with MAP1B mislocalization

Therapeutic Implications

MAP1B represents a potential therapeutic target in AD:

Microtubule-stabilizing compounds (epothilones, taxanes) can compensate for MAP1B dysfunction
GSK3β inhibitors reduce pathological MAP1B phosphorylation
AAV-mediated MAP1B expression may promote neuronal survival

Role in Parkinson's Disease

Axonal Pathology

In Parkinson's disease, MAP1B dysregulation contributes to early axonal changes:

Axonal Transport Deficits: Impaired microtubule-based transport in dopaminergic neurons[@badhwar2018][@park2023]

Dopaminergic Neuron Vulnerability: Specific vulnerability of substantia nigra pars compacta neurons

Alpha-Synuclein Interaction: MAP1B may interact with Lewy body pathology

Protein Kinase Links

Several PD-linked kinases regulate MAP1B:

LRRK2: Mutations in LRRK2 affect microtubule dynamics through MAP1B
PINK1/Parkin: Mitochondrial dysfunction affects MAP1B post-translational modifications
GSK3β: Enhanced activity contributes to MAP1B pathology

Role in Other Neurodegenerative Diseases

Huntington Disease

Axonal transport deficits via microtubule dysfunction
Interaction with mutant huntingtin protein
Dendritic abnormalities in striatal neurons

Amyotrophic Lateral Sclerosis

Axonal degeneration in motor neurons
Cytoskeletal disruption contributing to axonal dieback
Impaired organelle transport

Traumatic Brain Injury

MAP1B degradation as marker of axonal injury
Role in axonal repair and regeneration processes
Potential biomarker in cerebrospinal fluid

Neurodevelopmental Disorders

MAP1B variants associated with autism spectrum disorder
Mutations causing intellectual disability and cortical malformations
Lissencephaly associated with brain malformation

Signaling Pathways

Kinase Regulation

MAP1B function is regulated by multiple kinases:

Protein Interactions

MAP1B interacts with numerous proteins:

Tau: Coordination in microtubule binding, potential competitive interactions
CRMPs: Collapsin response mediator proteins in axon guidance
Kinesin/Dynein: Motor protein binding for axonal transport
Actin: Cytoskeletal cross-linking
L1CAM: Cell adhesion molecule in axon guidance
GSK3β: Bidirectional regulation of microtubule dynamics

Therapeutic Implications

Neuroprotective Strategies

Microtubule Stabilizers: Compounds that stabilize microtubules can protect against cytoskeletal disruption caused by MAP1B dysfunction[@cheng2023][@chen2024]

Kinase Inhibitors: Modulating GSK3β or CDK5 activity can regulate pathological MAP1B phosphorylation

Growth-Promoting Agents: Enhancing regenerative capacity through neurotrophic factors

Axonal Regeneration Approaches

MAP1B is being explored as a therapeutic target for spinal cord injury:

Gene Therapy: AAV-mediated MAP1B expression to promote axonal regeneration
Small Molecule Activators: Compounds that enhance MAP1B-microtubule interactions
Combinatorial Approaches: MAP1B with other neurotrophic factors (BDNF, NGF)

Drug Development

Several therapeutic strategies are being explored:

Epothilones: Microtubule-stabilizing compounds in clinical trials for AD
GSK3β Inhibitors: Lithium, tideglusib in clinical development
Neurotrophic Factors: BDNF and NGF delivery strategies

Biomarker Applications

MAP1B has potential as a biomarker:

CSF Markers: MAP1B fragments detectable in cerebrospinal fluid as markers of axonal injury
Neurodevelopment: Marker for neuronal differentiation
Disease Progression: Correlation with disease severity
Treatment Response: Potential marker for therapeutic efficacy

Animal Models

Multiple animal models have provided insights into MAP1B function:

Knockout Mice: Show developmental deficits in axon guidance and pathfinding
Transgenic Models: Reveal specific functions in synaptic plasticity
Conditional Knockouts: Adult-onset phenotypes for studying neurodegeneration
Point Mutants: Phosphorylation site mutants to study regulatory mechanisms

Research Directions

Current research directions include:

Super-resolution Microscopy: Mapping MAP1B organization in living neurons

Proteomics: Defining the MAP1B interactome in normal and diseased brain

iPSC Models: Patient-derived neurons for disease modeling

Axon Tracing: In vivo mapping of MAP1B-dependent pathways

Single-cell Sequencing: Cell-type specific expression patterns

Cross-References

[Tau Protein](/proteins/tau) - Related microtubule-associated protein in AD
[MAP2 Protein](/proteins/map2) - Related MAP family member
[Cytoskeletal Proteins](/proteins/) - Overview of neuronal cytoskeleton
[Alzheimer's Disease](/diseases/alzheimers-disease) - Disease context
[Parkinson's Disease](/diseases/parkinsons-disease) - Disease context
[Axonal Transport](/mechanisms/axonal-transport) - Transport mechanisms
[Microtubule](/entities/microtubule) - Cytoskeletal element
[Growth Cone](/entities/growth-cone) - Axon guidance structure

Key Publications

[Gonzalez-Billault et al., The role of MAP1B in axon guidance (2019)](https://pubmed.ncbi.nlm.nih.gov/31194248/)

[Takei et al., Enhanced phosphorylation of MAP1B in AD (2020)](https://pubmed.ncbi.nlm.nih.gov/33272345/)

[Teng et al., MAP1B mutations in neurodegenerative disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34564764/)

[Badhwar et al., MAP1B dysfunction in PD (2018)](https://pubmed.ncbi.nlm.nih.gov/29855542/)

[Meyer et al., MAP1B in tauopathy (2021)](https://pubmed.ncbi.nlm.nih.gov/33580928/)

[Cheng et al., Microtubule stabilization in AD (2023)](https://pubmed.ncbi.nlm.nih.gov/36863341/)

[Park et al., Axonal transport in MAP1B-deficient neurons (2023)](https://pubmed.ncbi.nlm.nih.gov/37200549/)

[Chen et al., Small molecule microtubule stabilizers (2024)](https://pubmed.ncbi.nlm.nih.gov/37666385/)

📖 View canonical wiki page →

Related Entities

MAP1BPROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-map1b-protein
kg_node_id	MAP1BPROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-e91adc10d164
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-map1b-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

65%

Debates

0

Incoming

13

Outgoing

15

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

MAP1B Protein

MAP1B Protein

Introduction

MAP1B Protein

Introduction

Overview

Protein Structure and Domains

Domain Organization

Light Chain Subunits

Post-Translational Modifications

Molecular Functions

Axon Growth and Guidance

Microtubule Organization

Synaptic Function

Expression Pattern

Developmental Regulation

Brain Regional Distribution

Role in Alzheimer's Disease

Pathological Changes

Amyloid-Beta Effects

Therapeutic Implications

Role in Parkinson's Disease

Axonal Pathology

Protein Kinase Links

Role in Other Neurodegenerative Diseases

Huntington Disease

Amyotrophic Lateral Sclerosis

Traumatic Brain Injury

Neurodevelopmental Disorders

Signaling Pathways

Kinase Regulation

Protein Interactions

Therapeutic Implications

Neuroprotective Strategies

Axonal Regeneration Approaches

Drug Development

Biomarker Applications

Animal Models

Research Directions

Cross-References

Key Publications

💬 Discussion